|
Screening for Chronic Kidney Disease and Referral System in Community Pharmacy |
|---|---|
| รหัสดีโอไอ | |
| Creator | Nunticha Somsiritragool |
| Title | Screening for Chronic Kidney Disease and Referral System in Community Pharmacy |
| Contributor | Monthip Mongkolsri, Ketkarn Wongphutorn, Thitiya Boonarsa, Parimoke Kerdchantuk |
| Publisher | Faculty of Pharmaceutical Sciences KKU MSU UBU |
| Publication Year | 2556 |
| Journal Title | Isan Journal ofPharmaceutical Sciences |
| Journal Vol. | 9 |
| Journal No. | 3 |
| Page no. | 74-81 |
| Keyword | chronic kidney disease, screening, questionnaire, pharmacy, referral |
| URL Website | https://tci-thaijo.org/index.php/IJPS |
| Website title | Isan Journal ofPharmaceutical Sciences, IJPS |
| ISSN | 19050852 |
| Abstract | Introduction: Chronic kidney disease is a chronic health problem, that early screening among patients is required to avoid the prognosis of the disease. Methods: This survey descriptive study aim toscreen and refer person who has risks for chronic kidney disease in community pharmacy. Selected persons with age40 years or over, and non- chronic kidney disease were referred from community pharmacy to Samakkhi and Burapha health center. All cases were screened by the questionnaire KIDs and proteinuria screening between 25 October and 25 December 2010. There were 214 participants with score 7 or higher and proteinuria, scored 7 or higher without proteinuria, scored 06 points with proteinuria, hematuria or a history of kidney stone. Those werereferred to health center then measured serum creatinine (SCr) and calculated glomerular filtration rate (GFR) to evaluate renal function. Results: 42 of 83 attendants (38.8%), who have risks for chronic kidney disease, were referred and measured serum creatinine., Mean SCr is 0.99?0.29 mg/dL and GFR is 76.66?27.49 mL/min/1.73 m2. 11 persons (26.2%) have GFR, which were e less than 60 mL/min/1.73 m2and 31 persons (74.8%) have GFR, which weremore than 60 mL/min/1.73 m2.. All have risk for chronic kidney disease only in stage 1, 2 and 3. Conclusion: Screening for chronic kidney disease has benefits because it decreased the prognosis of disease and receive appropriate management, therefore encourage screening for chronic kidney disease in community pharmacy. |
